Literature DB >> 21506689

Scientists' perception of ethical issues in nanomedicine: a case study.

Helena Silva Costa1, Sebastian Sethe, Ana P Pêgo, I Anna S Olsson.   

Abstract

AIM: Research and development in nanomedicine has been accompanied by the consideration of ethical issues; however, little is known about how researchers working in this area perceive such issues. This case-study explores scientists' attitude towards and knowledge of ethical issues.
METHOD: Data were collected by semi-structured interviews with 22 nanomedicine practitioners and subject to content analysis.
RESULTS: We found that scientists reflect with ambiguity on the reputed novelty of nanomedicine and what the ethical issues and risks are in their work. Respondents see no necessity for a paradigm shift in ethical considerations, but view ethical issues in nanomedicine as overlapping with those of other areas of biomedical research. Most respondents discuss ethical issues they faced in scientific work with their colleagues, but expect benefit from additional information and training on ethics.
CONCLUSION: Our findings that scientists are motivated to reflect on ethical issues in their work, can contribute to the design of new strategies, including training programs, to engage scientists in ethical discussion and stimulate their responsibility as nanomedicine practitioners.

Mesh:

Year:  2011        PMID: 21506689     DOI: 10.2217/nnm.11.9

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


  5 in total

1.  Why should nanoscience students be taught to be ethically competent?

Authors:  Anna Julie Rasmussen; Mette Ebbesen
Journal:  Sci Eng Ethics       Date:  2013-12-03       Impact factor: 3.525

2.  Effects of disciplinary cultures of researchers and research trainees on the acceptability of nanocarriers for drug delivery in different contexts of use: a mixed-methods study.

Authors:  Vanessa Chenel; Patrick Boissy; Jean-Pierre Cloarec; Johane Patenaude
Journal:  J Nanopart Res       Date:  2015-04-17       Impact factor: 2.253

3.  The role of philosophy of science in Responsible Research and Innovation (RRI): the case of nanomedicine.

Authors:  Gry Oftedal
Journal:  Life Sci Soc Policy       Date:  2014-04-26

4.  The acceptability of nanocarriers for drug delivery in different contexts of use: perceptions of researchers and research trainees in the field of new technologies.

Authors:  Vanessa Chenel; Patrick Boissy; Marie-Sol Poirier; Jean-Pierre Cloarec; Johane Patenaude
Journal:  Int J Nanomedicine       Date:  2015-03-16

5.  Analyses of Acceptability Judgments Made Toward the Use of Nanocarrier-Based Targeted Drug Delivery: Interviews with Researchers and Research Trainees in the Field of New Technologies.

Authors:  Vanessa Chenel; Patrick Boissy; Jean-Pierre Cloarec; Johane Patenaude
Journal:  Nanoethics       Date:  2015-10-29       Impact factor: 0.917

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.